IMCI Pharmaceuticals — raw details

Highlights

1 patentProfile claimed by owner

About

IMCI is Making Medical Cannabis: Safer, Effective, and Patient-Focused

IMCI Pharmaceuticals is a pharma-grade medical cannabis company redefining patient care through science, safety, and precision. Our proprietary NanoVATE™ drug-delivery platform enhances cannabinoid bioavailability, enabling fast, accurate, and long-lasting relief through our iCann product line: iCann Fast, iCann Oral, and iCann LA. With proven clinical results, exclusive IP, and EU-GMP-compliant manufacturing, IMCI is expanding across Europe, Israel, and the U.S., bringing standardized, effective, and stigma-free cannabis treatments to global markets.

🌿 IMCI is Making Medical Cannabis: Safer, Effective, and Patient-Focused

Identity

Name	IMCI Pharmaceuticals
Slug	imci-pharmaceuticals
Type / kind	startup
Source _id	agxzfmlsbGlzdHNpdGVyGAsSC05ld19Db21wYW55GICA4PXcltcJDA

Status

Status	active
Last update	2026-05-17

Location

HQ country code	IL
HQ region/district	Center District
HQ city	Gan Yavne
HQ address	Gan Yavne, Israel

Web & social

Website	https://www.imci-bv.com
LinkedIn	https://www.linkedin.com/company/imci-pharmaceuticals
Twitter / X	https://youtu.be/x4x5yhz-Vtc

Classifications

Primary sector Health Tech & Life Sciences

Sub-sectors

Health Tech & Life SciencesPharma & Medical BiotechnologyMedical CannabisDrugs Discovery & Development

Technologies

BiologicalsHerbals

Target customers

Healthcare & Life SciencesLife SciencesPharmaceuticals

Business models

B2B2CB2B

Funding

Total raised	—
Current stage	Pre-Funding

Raw source document

Show full JSON (0 KB)

{
  "0": "s",
  "1": "l",
  "2": "i",
  "3": "m",
  "4": "p",
  "5": "a",
  "6": "g",
  "7": "e",
  "8": "s",
  "9": "_",
  "10": "i",
  "11": "m",
  "12": "p",
  "13": "o",
  "14": "r",
  "15": "t"
}